Startup funding News

Biotech startup ApoGen, which is researching solutions to drug-resistant cancers, is moving into a new phase of development. The company announced Thursday that it has raised an additional $4 million as part of its series A round, bringing the total in that round to $11 million. The additional funding comes from M Ventures, the venture investment arm of German multinational healthcare company Merck KGaA, which shares a name with the American drug manufacturer. ApoGen said the funding will help the startup grow its team and establish its first independent lab and office in Seattle. The company was incubated by Accelerator… Read More

You might think diagnosing cancer is easy: Someone either has a cancerous tumor or they don’t. In practice, it’s much harder. Telling the difference between a deadly and a harmelss lump is literally “beyond our perception” with current imaging technology, Ilya Goldberg told GeekWire. That’s where he thinks artificial intelligence can step in. Goldberg is a longtime biologist and machine learning expert, and he is the co-founder and CTO of Mindshare Medical. The startup is developing artificial intelligence tools that can diagnose cancer using imaging data that is invisible to the human eye. On Thursday, Mindshare announced its image analysis product… Read More

StratoScientific, the Seattle-based startup that makes the Steth IO smart stethoscope, has raised $1.23 million to expand the use of its device. A company spokesperson, who confirmed the funding to GeekWire, said the funds come from a number of unnamed angel investors. Steth IO is a painstakingly designed phone case and app that turn any iPhone into a smart stethoscope that can hear, record and visualize patients’ heartbeats. It was invented by StratoScientific Co-founder and Chief Product Officer Suman Mulumudi when he was just 14 years old. The Steth IO spokesperson said this new funding will support the device’s expansion into the… Read More

Carewave Medical, a stealth mode startup backed by big names in Seattle’s biotech industry, has raised just over $3 million in new funding, according to an SEC filing. Carewave co-founder and CEO Al Stephan confirmed that the new funds are part of an ongoing round that GeekWire first reported in February. He added that he anticipates the round will close at $3.5 million but declined to comment further on the new funding or the company’s work. In addition to Stephan, the SEC filing names Ronald Chwang in relation to the company. Chwang is the chairman and president of health technology investment firm iD Ventures America.… Read More